Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77092442 | 7709244 | 2 | F | 20160610 | 20101214 | 20160804 | PER | US-ASTRAZENECA-2010SE33090 | ASTRAZENECA | 0.00 | M | Y | 113.40000 | KG | 20160805 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 77092442 | 7709244 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 40 | MG | TABLET | QD | |||||||
| 77092442 | 7709244 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 20 | MG | TABLET | QD | |||||||
| 77092442 | 7709244 | 3 | C | OMEGA 3 FISH OIL | FISH OILOMEGA-3 FATTY ACIDS | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 77092442 | 7709244 | 1 | Blood cholesterol increased |
| 77092442 | 7709244 | 2 | Blood cholesterol increased |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 77092442 | 7709244 | Blood cholesterol increased | |
| 77092442 | 7709244 | Blood triglycerides increased | |
| 77092442 | 7709244 | Drug dose omission | |
| 77092442 | 7709244 | High density lipoprotein decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 77092442 | 7709244 | 1 | 1996 | 0 |